it is not clear what is and what is not included in a condition.
E.g., what is the difference in 3 parkinsonic phenotypes
(e.g., difference in parkinsonism and parkinson disease)
Also, how are conditions grouped - what decides what is selected as a "leaf node"? (how groups are decided)
(why I can't say all "Extrapyramidal and movement disorders"
When a user reviews evidence for a given drug-condition http://www.ohdsi.org/web/howoften/#!/1353766/381270
it is not clear what is and what is not included in a condition. E.g., what is the difference in 3 parkinsonic phenotypes
(e.g., difference in parkinsonism and parkinson disease)
Also, how are conditions grouped - what decides what is selected as a "leaf node"? (how groups are decided) (why I can't say all "Extrapyramidal and movement disorders"